News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Anthera Pharmaceuticals, Inc. (JOBS) IPO Closes Up 1 Cent in The Nasdaq Stock Market -- New York Debut
March 2, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Shares in biopharmaceutical company Anthera Pharmaceuticals Inc (ANTH.O) closed 1 cent above their initial public offering price on Monday, in a postponed and downsized deal.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
·
3 min read
·
Annalee Armstrong
IPOs
MapLight Keeps Biopharma’s IPO Flame Alight To Advance Alzheimer’s, Schizophrenia Drugs
September 22, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
September 15, 2025
·
2 min read
·
Tristan Manalac
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
·
2 min read
·
Annalee Armstrong
